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ABSTRACT
Transcriptome analyses have typically disregarded
nucleocytoplasmic differences. This approach has
ignored some post-transcriptional regulations and
their effect on the ultimate protein expression
levels. Despite a longstanding interest in the differ-
ences between the nuclear and cytosolic
transcriptomes, it is only recently that data have
become available to study such differences and
their associated features on a genome-wide scale.
Here, we compared the nuclear and cytosolic
transcriptomes of HepG2 and HeLa cells. HepG2
and HeLa cells vary significantly in the differential
compartmentalization of their transcript isoforms,
indicating that nucleocytoplasmic compartmen-
talization is a cell-specific characteristic. The differ-
ential compartmentalization is manifested at the
transcript isoform level instead of the gene level
because alternative isoforms of one gene can
display different nucleocytoplasmic distributions.
The isoforms enriched in the cytosol tend to have
more introns and longer introns in their pre-mRNAs.
They have more functional RNA folds and unique
exons in the 30 regions. These isoforms are more
conserved than the isoforms enriched in the
nucleus. Surprisingly, the presence of microRNAs
does not have a significant impact on the
nucleocytoplasmic distribution of their target
isoforms. In contrast, nonsense-mediated decay is
significantly more associated with the isoforms
enriched in the nucleus than those enriched in the
cytosol.
INTRODUCTION
Gene expression regulation comprises multiple levels
including transcription, splicing, nuclear export,
microRNA (miRNA) inhibition and mRNA decay.
Because protein translation occurs in the cytoplasm,
the compartmentalization of mature mRNA in the
nucleus and the cytosol has an immediate impact on pro-
tein expression levels. The compartmentalization is closely
related to the export kinetics of mRNA from the nucleus
to the cytoplasm and the degradation rate of mRNA in
the cytoplasm. Both of these processes are fundamental to
gene expression regulation (1). Transcriptome analyses
have typically proﬁled polyadenylated (poly(A)
+) tran-
scripts without tracking nucleocytoplasmic diﬀerences.
This may not interfere with studies on transcriptional reg-
ulation but ignores post-transcriptional regulation and its
eﬀect on the ultimate output of gene expression regula-
tion, the protein translation level. It is thus necessary to
understand the diﬀerence between the nuclear and
cytoplasmic transcriptomes. It is equally important to
investigate whether the nucleocytoplasmic compartmen-
talization of mRNA transcripts displays any global
features and/or reﬂects any cell-speciﬁc characteristics.
The nucleocytoplasmic compartmentalization of
mRNA has an immediate impact on the protein expres-
sion level. Meanwhile, alternative pre-mRNA splicing is
an important gene regulation mechanism for expanding
proteomic diversity in higher eukaryotes because
multiple transcript isoforms produced from a single gene
can lead to protein isoforms with distinct functions (2).
It has been estimated that >90% of human genes are
alternatively spliced (3,4). Little is known about the
nucleocytoplasmic compartmentalization of alternative
transcripts on the global scale. Therefore, there is great
interest in studying the diﬀerence between the nuclear
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vidual transcript isoform level. Recently, we developed
Bayesian Analysis of Splicing IsoformS (BASIS) to
compare transcriptomes at the individual transcript
isoform level (5). This is achieved by a hierarchical
Bayesian model based on the high-throughput sequencing
data or the high-resolution tiling array data and transcript
isoform splicing patterns assembled from databases.
Here, we applied BASIS to a high-density tiling array
data set to compare individual transcript isoforms
between the nucleus and the cytosol of HepG2 and
HeLa cells. The array data are from the Kapranov
et al.’s (6) in which they proﬁled the steady-state nuclear
and cytosolic poly(A)
+ RNAs >200nt using the
whole-genome 5bp resolution tiling arrays. Based on
the results from BASIS, we identiﬁed transcript
isoforms enriched in the nucleus or in the cytosol. In the
rest of the article, we will call these enriched classes
nuclear isoforms and cytosolic isoforms, respectively
(although ‘nuclear isoforms’ do not necessarily mean
that they are not found in the cytosol, and vice versa).
For the ﬁrst time on a genome-wide scale, we discovered
some global features of nuclear isoforms and cytosolic
isoforms.
Introns and their splicing have been reported to aﬀect
gene expression at many diﬀerent levels, including tran-
scription (7–12), polyadenylation (13,14), mRNA export
(15–21), translational eﬃciency (22–24) and mRNA
decay (25). In Xenopus oocyte injection experiments,
mRNAs generated through splicing are exported to the
cytoplasm more rapidly than identical mRNAs
transcribed from intron-free cDNA constructs (15–17).
In mammalian cells, studies on the SV40 gene (19) and
the human ceruloplasmin gene (20) show that splicing eﬃ-
ciently exports mRNAs to the cytoplasm. Tokunaga et al.
(21) microinjected ﬂuorescently labeled ftz pre-mRNA
into mammalian cell nuclei, and found that the spliced
mRNAs were eﬃciently exported but the intron-less
mRNA was diﬀusely distributed in the nucleus. More
recently, Valencia et al. (18) used a similar approach
combining FISH and transfection or nuclear
microinjection to re-examine the relationship between
splicing and mRNA export in mammalian cells. They
concluded that splicing promotes rapid and eﬃcient
mRNA export. As a result of pre-mRNA splicing, a set
of proteins called the exon junction complex (EJC) are
deposited on the mRNA upstream of exon–exon junc-
tions. The EJC can provide a binding platform for the
mRNA export machinery and link the excision of
introns with mRNA export (1,15,26). In addition,
introns can regulate mRNA degradation rates (25). To
explore the eﬀect of introns on nucleocytoplasmic
mRNA distribution on a genomic scale, we examined
various attributes of the introns for the nuclear and
cytosolic isoforms.
We then compared the enrichment of functional RNA
folds between the nuclear and cytosolic isoforms. The
untranslated regions (UTRs) of mRNAs contain
multiple cis-acting elements that regulate mRNA export,
stability, and sub-cellular localization (27). Many of these
cis-acting elements contain secondary structures such as
stem loops but lack recognizable primary sequence
features (28,29). We therefore performed the functional
RNA fold studies for the nuclear and cytosolic isoforms.
Next, we examined the relationship of miRNAs and
diﬀerentially distributed isoforms. miRNAs inhibit
protein translation by base pairing imperfectly to the
30 UTR of their target genes in animals (30,31). In
some instances, this induces mRNA degradation
(32,33) and thus may aﬀect the dynamics of mRNA
nucleocytoplasmic localization. We therefore investigated
the global impact of miRNAs on the mRNA transcript
nucleocytoplasmic distribution. We also examined the
relationship between nonsense-mediated decay (NMD)
and the diﬀerential compartmentalization of transcript
isoforms. NMD degrades mRNAs that carry premature
translation termination codons (34–36). It has been shown
to be coupled with alternative splicing to control protein
expression levels or malicious protein expression (termed
AS-NMD). The studies on the global prevalence of func-
tional AS-NMD have conﬂicting views (37,38). EST and
cDNA sequence-based analyses predicted that  35% of
alternative splicing events have the potential to be
regulated by NMD (37), but microarray-based studies
show that these transcript isoforms are generally
produced at low levels and are independent of the action
of NMD (38). Because NMD occurs in the cytosol, it may
impact the nucleocytoplasmic distribution of a transcript
isoform. Finally, we compared the conservation levels of
the nuclear isoforms with those of the cytosolic isoforms.
MATERIALS AND METHODS
Tiling array data pre-processing
The non-redundant transcript isoform information for
human genes was downloaded from the Alternative
Splicing and Transcript Diversity database (39)
(http://www.ebi.ac.uk/astd/, release 1.1, names begin
with ‘TRAN’) and the Ensembl Genome Browser
(http://www.ensembl.org/index.html, release 50, names
begin with ‘ENST’). The expression levels of these tran-
scripts were from the whole-genome tiling arrays in which
the human genome is split into 91 chips with 5bp resolu-
tion (6). We studied the expression data for the HeLa and
HepG2 cell lines in the cytosol and the nucleus. Each cell
line had about three replicates. The proﬁled RNAs were
polyadenylated and >200nt. The preprocessed probe
signal and the transcribed regions (transfrags) were
downloaded from the GEO database with the accession
number GSE7576 (http://www.ncbi.nlm.nih.gov/geo).
The signal thresholds for the transfrags correspond to a
4% false discovery rate. The probe intensity was further
quantile-normalized for the cytosol and nucleus. The
probe coordinates were from the NCBI version 35. The
UCSC liftOver tool (http://genome.ucsc.edu/) was used to
convert the coordinates between version 35 and version
36. We treated transcripts as ‘present’ if  50% of their
exons had  50% of their positions overlapping with
transfrags. Among the 20892 protein-coding genes [note
that some transcript isoforms do not have ‘coding
sequence (CDS)’ features available], 9953 genes for
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none of their transcripts was present in either sub-cellular
location. In our pre-screening procedures, we removed
genes with incompletely spliced transcripts. If an intron
had  50% positions overlapping with transfrags, we
treated it as an unspliced intron. Only 3–8% of introns
were un-spliced. This indicates that polyadenylation
occurs after splicing is mostly ﬁnished. If a transcript
contained un-spliced introns, we treated it as an
incompletely spliced transcript and removed the gene
(1196 genes for HepG2 and 1015 genes for HeLa).
According to the procedures, we also removed genes
with retained introns, which are considered a special
category of alternative splicing. However, it is generally
agreed that it is diﬃcult to distinguish intron retention
from experimental artifacts (e.g. incomplete splicing).
Other pre-screening procedures were performed as
described previously (5), and an additional 1192 genes
for HepG2 and 1189 genes for HeLa were removed.
A total of 8551 genes with 67680 possible transcript
isoforms were considered in BASIS for HepG2, and a
total of 9081 genes with 70902 possible transcript
isoforms were considered in BASIS for HeLa.
Hierarchical Bayesian model (BASIS)
For each exonic probe i of gene g, consider the linear
model:
 ygi ¼
X
  gjxgij þ  "gi
where  ygi is the intensity diﬀerence between two
sub-cellular locations for probe i of gene g ðy
1
gi y2
giÞ,
 bgj is the expression diﬀerence between two locations
for the jth transcript isoform of gene g, xgij is the binary
indicator whether probe i belongs to isoform j’s exon
region, and  egi is the error term of probe i of gene g.
For a dataset, g is from 1 to G where G is the total number
of genes, i is from 1 to ng where ng is the total number of
probes for gene g, and j is from 1 to sg where sg is the total
number of transcript isoforms for gene g. The total  egi’s
(g=1,...,G and I=1,...,ng) are divided into 100 bins.
Each bin contains thousands of probes with similar
y1
gi þ y2
gi values. Because the intensity variance is depen-
dent on the intensity mean, probes in the same bin will
have similar variances.
A hierarchical Bayesian model is built as:
 Ygj"bg,Dg   NngðXg"bg,DgÞ, g¼1,...,G;
"bgjcg   Nsgð0,RgÞ;
Rg   diagð g1,..., gsgÞ, gj ¼  gj if gj ¼ 0and gj ¼  gj if gj ¼ 1;
fðcgÞ¼
Y sg
j¼1
p gjð1   pÞ
1  gj;
Dg   diagð 1,..., ngÞ, i ¼  m ifprobei binm
 m   IGð =2,  =2Þ,m ¼ 1,...,100
where cg is a latent variable, Nng and Nsg stand for
multivariate normal distributions, IG stands for inverse
gamma distribution. When ggj=0,  bgj N(0,t) and
when ggj=1,  bgj N(0,w). We set t to be small so
that when ggj=0,  bgj is small enough to be estimated
as 0. And w is set to be large so that when ggj=1, bgj is
big enough to be included in the ﬁnal model. Therefore,
the latent variable g can perform variable selection for the
regression model. The errors of probes belonging to the
same gene can be heteroscedastic through the bin assign-
ment. Through BASIS, we can identify transcript isoforms
that are diﬀerentially distributed between two sub-cellular
locations. The details about BASIS can be found in Zheng
et al. (5). Hyperparameters of the model include
ð , ,p, , Þ and we chose the default parameters. We
used 100 as the initial value for each dm. A total of
10000 burn-in iterations followed by 40000 iterations
were generated to estimate the posterior probabilities.
Transcript isoforms with prob (g=1|data)>0.5 were
declared diﬀerentially distributed. Then, for each gene, the
R
2-value was used to assess the overall ﬁt of the regression
model, which includes the declared diﬀerentially
distributed isoforms only. The regressions with R
2<0.5
were excluded from further analyses. If the  b estimate
for the diﬀerentially expressed transcript was positive, the
isoform was declared to be enriched in the cytosol (or
cytosolic isoforms). Otherwise, the isoform was declared
to be enriched in the nucleus (or nuclear isoforms).
The predictions are accessible athttp://www-rcf.usc
.edu/ liangche/software.html. Other statistical tests were
performed using R software.
Other data sources
The PhastCons conservation score (40) was downloaded
from the UCSC Genome Browser (http://genome.ucsc
.edu/, hg18). The score of each site is the posterior prob-
ability that the site is in the conserved state of the
phylogenetic hidden Markov model for 17 vertebrates.
The average PhastCons score for the positions of introns
was used as the conservation measure for introns. The
average PhastCons score across every exonic position of
transcript isoforms was used to represent the conservation
level of transcripts.
The predicted EvoFold structures (41) were
downloaded from the UCSC Genome Browser. These
are the predicted functional RNA secondary structures
based on probabilistic models of RNA secondary struc-
ture and primary sequence evolution across eight
vertebrates.
The miRNA target sites were downloaded from the
miRBase Targets database (http://microrna.sanger.ac
.uk/targets/v5/). These are the predicted miRNA targets
that are highly complementary sites to the given miRNA
sequences, and the sites are conserved across species.
The miRNA expression data was from the Landgraf
et al. (42). Landgraf and colleagues cloned and sequenced
more than 330000 small RNA sequences from 256 small
RNA libraries. The cloning frequencies of the miRNAs
were used as a measure of the miRNA expression for
more than 300 distinct mature human miRNAs. In total,
there were 96 miRNAs with a least one clone in the
HepG2 cell line and 104 miRNAs present in the HeLa
cell line.
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We identiﬁed the unique exon of the CAPN1 transcript
TRAN00000084965 and the BCL6 transcript
ENST00000232014. Thus, the expression level of this
exclusively included exon can represent the expression
level of the transcript isoform that includes it. A diﬀerent
exon that does not belong to the tested isoform but
belongs to a non-diﬀerentially localized isoform was
used as a control. The nuclear and cytosolic poly(A)
+
RNAs of HepG2 cells were provided by Dr Gingeras’
group. The nuclear and cytosolic RNAs were DNase I
(Roche) treated and reverse transcribed with SuperScript
III (Invitrogen) according to the manufacturer’s instruc-
tions. The PCR reactions contained 200000–500000
counts per minute of the
32P-labeled common primer.
Multiplex PCR of the test transcript and the control tran-
script used one common primer and two speciﬁc primers.
The PCR reactions were run in an MJ Research PTC-200
thermocycler for 22–26 cycles, depending on the gene
expression levels with an annealing temperature of 60 C.
The PCR reactions were mixed 1:1 with 95% formamide
and loaded onto 8% polyacrylamide, 7.5M urea gels and
electrophoresed. Subsequently, the gels were dried
and imaged on a Typhoon PhosphorImager (Molecular
Dynamics). The primer sequences are as follows:
CAPN1: (F) CGGATGACCCGGACGACTAC, (R1) G
GGGTGTGTGACTGCAGGTG, (R2) TGCTGACCTC
TCGCAGGTTG; BLC6: (F1) AAGTCCTCCCCTGCC
ACGTA, (F2) TCCCTTCCCCACTTCCTTCC, (R) TG
CCTTGCTTCACAGTCCAA.
RESULTS
The hierarchical Bayesian model BASIS was developed to
infer diﬀerentially distributed transcript isoforms on the
individual isoform level. In BASIS, we introduced a latent
variable g=( g1, ..., gs)
T where gj=1 means that the j-th
isoform is diﬀerentially distributed and gj=0 means that
it is not diﬀerentially distributed. The probes for the same
gene can be assigned to diﬀerent bins and each bin has a
unique variance parameter. Therefore, BASIS can handle
the heteroscedastic errors of probe intensity. A homoge-
neous ergodic Markov chain was generated by our Gibbs
Sampler. The details can be found in our previous work
with a discussion about the convergence and the
robustness of the model (5).
HepG2 and HeLa cells contain diﬀerent nuclear and
cytosolic isoforms
Among the 67680 isoforms that passed the pre-screening
procedures and were considered in BASIS for HepG2
cells, 7590 of them were nuclear isoforms and 6901 of
them were cytosolic isoforms (Figure 1A). Among the
70902 isoforms considered for HeLa cells, 11529 were
nuclear isoforms and 10139 were cytosolic isoforms. To
understand whether the diﬀerential nucleocytosolic
compartmentalization was at the gene level or at the tran-
script isoform level, we separated genes into four
categories according to whether they contained nuclear
isoforms and/or cytosolic isoforms. In the HepG2 cell
line (Figure 1B), 25.0% of the considered genes had
both nuclear and cytosolic isoforms (category 1), 7.3%
of them had cytosolic isoforms but no nuclear isoforms
(category 2), and 2.7% of them had nuclear isoforms but
no cytosolic isoforms (category 3). The remaining genes
(65%) did not have nuclear isoforms or cytosolic isoforms
(category 4). The percentages for HeLa cells were 35.9%
for category 1, 11.9% for category 2, 5.6% for category 3
and 46.6% for category 4 (Figure 1C). Apparently, a
majority of genes with diﬀerentially distributed isoforms
(categories 1 to 3) contained both nuclear isoforms and
cytosolic isoforms (category 1). In addition, many genes in
categories 1–3 contained isoforms that were not
diﬀerentially distributed between the nucleus and the
cytosol, further indicating the multiplicity in the mRNA
nucleocytosolic distribution for a given gene. Therefore,
the diﬀerential compartmentalization of mRNA is
not gene-speciﬁc but instead is alternative isoform-
speciﬁc. Meanwhile, we also observed the cell-speciﬁc
nucleocytosolic compartmentalization of transcript
isoforms. Despite some overlap, HepG2 and HeLa
contained diﬀerent nuclear and cytosolic isoforms
(Figure 1A). Large numbers of transcript isoforms were
diﬀerentially distributed in one cell line but not in the
other cell line. Such a diﬀerence was not completely due
to cell-speciﬁc transcription. Among the diﬀerentially
distributed transcript isoforms unique to HepG2
(3729+4255=7984), 80.5% of them were present in
HeLa. Among the diﬀerentially distributed transcript
isoforms unique to HeLa (7107+8054=15161), 77.2%
of them were present in HepG2. The results indicate that
the nucleocytosolic localization of a transcript isoform can
be cell type-speciﬁc. It also implies another type of
cell-speciﬁc post-transcriptional regulation. Figure 1D
and E shows examples of diﬀerentially distributed
isoforms, which were conﬁrmed by isotope-labeled
RT-PCR. The CAPN1 transcript TRAN00000084965
contains an alternative exon 12a and was a nuclear
isoform. Another transcript isoform, ENST00000279247,
contains exon 12 and was not diﬀerentially distributed.
The BCL6 transcript ENST00000232014 has a promoter
at exon 1a and was enriched in the nucleus. Transcript
isoform ENST00000406870 has an alternative promoter
at exon 1 and was not diﬀerentially distributed.
Additional validation experiments for the BASIS model
itself have been described by Zheng et al. (5).
Introns and the nucleocytosolic distribution of mRNA
The diﬀerential compartmentalization of mRNA is a man-
ifestation of various regulatory mechanisms from nuclear
export to cytosolic mRNA decay. For example, transcript
isoforms enriched in the cytosol may result from an eﬃ-
cient nuclear export and slow mRNA decay. Although the
detailed mechanisms of mRNA export remain to be
clariﬁed, it appears that pre-mRNA splicing substantially
enhances the nuclear export eﬃciency (16). We were inter-
ested to know if the diﬀerential compartmentalization of
mRNA transcript isoforms was related with pre-mRNA
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Figure 1. The diﬀerentially distributed isoforms predicted by BASIS. (A) A Venn diagram of the cytosolic and nuclear isoforms for the HepG2 and
HeLa cell lines. The genes considered in the BASIS analysis for HepG2 (B) or HeLa (C) can be divided into four categories. Category 1: genes
having both cytosolic isoforms and nuclear isoforms (2136 and 3258 for HepG2 and HeLa, respectively). Category 2: genes having cytosolic isoforms
but no nuclear isoforms (626 and 1083). Category 3: genes having nuclear isoforms but no cytosolic isoforms (235 and 506). Category 4: genes
having no diﬀerentially distributed transcript isoforms (5554 and 4234). (D)–(E) The isotope-labeled RT-PCR of the CAPN1 and BCL6
transcripts in HepG2 cells. The forward and reverse primer positions are labeled with F or R. (D) CAPN1: Exon 12a is uniquely present in the
test isoform, TRAN00000084965, which was predicted to be enriched in the nucleus. Exon 12 is present in a non-diﬀerentially distributed tran-
script isoform, ENST00000279247. (E) BCL6: The test isoform, ENST00000232014, has a promoter at exon 1a and was predicted to be enriched
in the nucleus. Another isoform, ENST00000406870, has an alternative promoter at exon 1 and was used as a control. N, nuclear samples;
C, cytosolic samples.
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intron numbers (i.e. the numbers of exon–exon junctions).
The median number of introns was ﬁve for HepG2
cytosolic transcripts and three for HepG2 nuclear tran-
scripts. In the HeLa cell line, the median intron number
was four for the cytosolic transcripts and three for the
nuclear transcripts. For the transcript isoforms enriched
in the cytosol of both cell lines, the median intron number
was ﬁve. For the transcript isoforms enriched in the
nucleus of both cell lines, the median number decreased
to three. Such a diﬀerence was signiﬁcant (the P-values
based on the one-sided Wilcoxon test <2.2 10
 16).
Because the genes with retained introns were not consid-
ered in our analysis (see ‘Materials and Methods’ section),
the alternative splicing of retained introns cannot explain
the diﬀerence. The diﬀerence is also not due to the cassette
exon inclusion in which an intron is broken into one
cassette exon and two shorter introns so that the intron
number is increased by one. Speciﬁcally, the isoforms
including cassette exons were not particularly associated
with the nuclear isoforms or the cytosolic isoforms
compared with the isoforms excluding cassette exons
(the P-value based on the chi-squared test was 0.27 for
HepG2 and 0.14 for HeLa).
We further investigated the length of the introns speciﬁc
to the cytosolic or nuclear isoforms. To our surprise, the
introns speciﬁc to the cytosolic isoforms were signiﬁcantly
longer than those speciﬁc to the nuclear isoforms
(the P-values based on the one-sided Wilcoxon test
<2.2 10
 16). The median length of the introns speciﬁc
to the cytosolic isoforms was about 1.7–2.9 times longer
than that of the introns speciﬁc to the nuclear isoforms. In
addition, the median length of the introns speciﬁc to the
non-diﬀerentially distributed transcript isoforms was
between those of the cytosolic isoforms and the nuclear
isoforms. On the contrary, the exon lengths among the
three groups were almost the same. Table 1 lists the
median length of the introns and exons speciﬁc to the
nuclear isoforms, cytosolic isoforms or non-diﬀerentially
distributed isoforms. Because the cytosolic isoforms had
more introns and their unique introns were longer, they
had a much larger fraction of intronic regions at the
pre-mRNA level than the nuclear isoforms (the P-values
based on the one-sided Wilcoxon test <2.2 10
 16).
Figure 2 shows the boxplot of the intronic proportion.
These analyses were carried out by counting the individual
isoforms. We performed similar analyses by counting the
individual gene loci to exclude the possible bias introduced
by the diﬀerent numbers of transcript isoforms for the
diﬀerent genes. Speciﬁcally, we averaged the intronic pro-
portions of the nuclear isoforms (or cytosolic isoforms)
from the same gene and used the mean values for the
boxplots. The results were similar (Supplementary Data
1). If we excluded category 1 genes (genes with both
nuclear and cytosolic isoforms) or considered category 1
genes alone, the patterns were still similar to Figure 2
(Supplementary Data 2 and 3). We have also studied the
intron conservation. Based on the PhastCons (40) conser-
vation scores, the introns speciﬁc to the cytosolic isoforms
tended to be more conserved than those speciﬁc to the
nuclear isoforms. The median conservation level was
0.063 versus 0.046 for HepG2 and 0.064 versus 0.051 for
HeLa. The P-values based on the one-sided Wilcoxon test
were <2.2 10
 16.
Functional RNA secondary structures and the
nucleocytosolic distribution
RNA secondary structure is involved in mRNA nuclear
export and mRNA stability. We thus studied whether the
Table 1. The lengths of the introns and exons speciﬁc to the cytosolic isoforms, nuclear isoforms or non-diﬀerentially distributed isoforms
Median intron length (in bp) Median exon length (in bp)
Cytosol Nucleus Non-diﬀerentially
distributed
Cytosol Nucleus Non-diﬀerentially
distributed
HepG2 2165 1088 1739 139 154 144
HeLa 2319 1369 1804 142 150 145
Both 2307 802 1806 141 158 145
The non-redundant introns and exons speciﬁc to the cytosolic isoforms, nuclear isoforms or non-diﬀerentially distributed isoforms were collected to
calculate the median length. The isoforms are for the HepG2, HeLa or both cell lines. Some of the transcript isoforms contain no intron and did not
contribute to the calculation. The introns and exons shared by the cytosolic isoforms, nuclear isoforms and non-diﬀerentially distributed isoforms
were excluded from the analysis.
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Figure 2. The intronic proportions of cytosolic and nuclear isoforms.
The intronic proportion was calculated as [intronic region (in bp)]/
[intronic region (in bp) + exonic region (in bp)]. Note that the cytosolic
isoforms have larger intronic proportions. The boxplots are for the
transcripts enriched in the cytosol or the nucleus of HepG2, HeLa or
both cell lines.
Nucleic Acids Research,2010, Vol.38, No. 4 1091cytosolic and nuclear isoforms have distinct patterns
of RNA secondary structures. The average coverage of
functional RNA folds at each position of the 50 region
and the 30 region was calculated for both the nuclear
and cytosolic isoforms (Figure 3). In general, the
30 regions were more likely to contain a functional RNA
fold than the 50 regions (median average coverage
0.0063–0.0084 versus 0.0033–0.0042). Interestingly, the
cytosolic isoforms were more likely to contain a functional
RNA fold in the 30 region than the nuclear isoforms
(median average coverage 0.0077–0.0084 versus 0.0063).
The P-value based on the one-sided Wilcoxon test was
<2.2 10
 16 for either HepG2 cells or HeLa cells.
Potential miRNA targets and the nucleocytosolic
distribution
miRNAs are important regulators of translation and
mRNA degradation (33). The miRNA-mediated silencing
of mRNAs occurs in the cytosol. If the miRNA-mediated
mRNA degradation is superior to the nuclear export of
mRNAs, we expect miRNA target transcripts to be
enriched in the nucleus. Hypergeometric test was per-
formed to test whether the nuclear or cytosolic isoforms
tended to be the targets of miRNA. The results are
summarized in Table 2. To our greatest surprise, the
P-values for the enrichment of the cytosolic isoforms
with miRNA targets were very signiﬁcant (<1.0 10
 14),
whereas the P-values for the nuclear isoforms were close
to one. Thus, there were many more cytosolic isoforms
with miRNA target sites than expected by chance. On
the contrary, there were far fewer nuclear isoforms with
miRNA target sites than expected by chance. Such an
analysis only takes into account whether the cis-elements
of an isoform could be the miRNA target sites regardless
of the miRNA expression.
It is interesting to investigate whether the physical
presence of miRNA would change the results. We
obtained the miRNA expression data of the HepG2 and
HeLa cell lines from the Landgraf et al. (42). Both the
cytosolic and nuclear isoforms were further separated
into three groups: (i) isoforms with at least one target
site of expressed miRNAs; (ii) isoforms with the target
site(s) of only non-expressed miRNAs; and (iii) isoforms
without any miRNA target sites. As shown in Figure 4,
for transcript isoforms without any miRNA target sites
(white bars or group 3), the ratio between the number of
cytosolic isoforms and the number of nuclear isoforms
was 0.66, 0.56 and 0.47 for the HepG2 cell line, the
HeLa cell line and both cell lines, respectively. For the
transcript isoforms that have miRNA target sites but
none of the corresponding miRNAs present in the cell
(grey bars or group 2), these ratios increased to 1.28,
1.39 and 1.65, respectively. If any of the corresponding
miRNA(s) was present in the cell (black bars or group
1), the ratios were 1.30, 1.40 and 1.65, respectively,
which are not signiﬁcantly diﬀerent from those of group
2. The fact that the miRNA expression does not impact
these ratios indicates that the miRNA-mediated mRNA
decay in the two human cell lines is not a signiﬁcant con-
tributor to the diﬀerential nucleocytosolic compartmen-
talization of the transcript isoforms.
NMD and the nucleocytosolic distribution
NMD degrades abnormal mRNAs that prematurely ter-
minate translation. Some alternative splicing events also
exploit NMD to achieve quantitative post-transcriptional
regulation (AS-NMD). In our studies, we identiﬁed NMD
targets if a transcript has a premature termination codon
(PTC) that occurs >50nt upstream of the ﬁnal splice
junction. The criterion was the same as found in the
work by Nagy et al. (43). About 6.8% of the cytosolic
isoforms with CDS features in HepG2 were predicted to
have a PTC and may trigger NMD. The percentage
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Table 2. The nucleocytosolic locations of transcripts and the presence
of miRNA target sites
With miRNA
target site(s)
Without miRNA
target site(s)
P-value
Total 65398 60862
HepG2: cytosol 3883 3018 8.62 10
 15
HepG2: nucleus 2991 4599 1.00
HeLa: cytosol 6121 4018 1.49 10
 73
HeLa: nucleus 4378 7151 1.00
Both: cytosol 1747 897 2.59 10
 51
Both: nucleus 1053 1894 1.00
Among the 126260 transcript isoforms assembled from databases,
65398 of them contain a possible miRNA target site. ‘HepG2:
cytosol’ means the cytosolic isoforms in HepG2 cells. The same
applies to the other groups. The counts of the transcript isoforms
with or without miRNA target sites are listed. The P-value is the prob-
ability of randomly drawing the same or higher number of transcript
isoforms with miRNA target sites. It was calculated based on the
hypergeometric test.
1092 Nucleic Acids Research, 2010,Vol.38, No. 4increased to 11.3% for the nuclear isoforms. The percent-
ages for HeLa were 5.6 versus 10.0%, respectively. Thus,
the nuclear isoforms had higher proportions of NMD
targets than the cytosolic isoforms. The P-value based
on the chi-squared test was 4.6 10
 12 for HepG2 and
<2.2 10
 16 for HeLa. These results seem to be consistent
with the hypothesis because NMD targets are degraded in
the cytosol, they tend to be enriched in the nucleus.
However, the presence of NMD targets in some cytosolic
isoforms indicates that the NMD eﬀect may be selective to
certain isoforms or NMD rate is slower than the export
rate for certain isoforms.
The conservation score and the nucleocytosolic distribution
We have mentioned that the introns speciﬁc to the
cytosolic isoforms were more conserved than the introns
speciﬁc to the nuclear isoforms. For the exonic regions,
the quantile–quantile plot of the conservation levels
(Figure 5A) also shows that the cytosolic isoforms were
much more conserved than the nuclear isoforms.
Nevertheless, the transcript isoforms belonging to one
gene locus contain both shared and unique exonic
regions. To further dissect the diﬀerence in these regions
between the cytosolic and nuclear isoforms, we then
focused on the genes that had both the cytosolic and
nuclear isoform(s) (category 1in Figure 1B and C). Such
a gene has three diﬀerent types of exonic regions: exonic
regions shared by both the cytosolic and nuclear
isoform(s) exonic regions unique to the cytosolic
isoform(s) and exonic regions unique to the nuclear
isoform(s). The shared exonic positions were signiﬁcantly
more conserved (median conservation level 0.992) than the
unique exonic positions (the P-values based on the
one-sided Wilcoxon test <2.2 10
 16, Figure 5B). This
most likely reﬂects the higher conservation in constitutive
exons than in alternative exons globally (44). Interestingly,
the exonic positions speciﬁc to the cytosolic isoforms were
more conserved than those speciﬁc to the nuclear isoforms
(median conservation level: 0.224 versus 0.002 for HepG2,
0.062 versus 0.005 for HeLa, the P-values based on the
one-sided Wilcoxon test <2.2 10
 16). In addition, we
observed a bi-modal distribution of the conservation
scores (see the density curves in Figure 5B). Even for the
exonic positions speciﬁc to the nuclear isoforms, a small
number of the positions showed high conservation levels,
although the majority of them had low conservation
levels. When we looked at the relative positions of these
exonic positions, those speciﬁc to the cytosolic isoforms
tended to be at the 30 termini of genes (Figure 6A and D).
However, the exons speciﬁc to the nuclear isoforms tended
to be in the middle of genes (Figure 6B and E).
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In this article, we have applied a hierarchical Bayesian
model (BASIS) to identify diﬀerentially distributed
splicing isoforms between the nucleus and cytosol in the
HepG2 and HeLa cell lines. The diﬀerential distribu-
tion of transcript isoforms was cell type speciﬁc
(see Figure 1A). A total of 29652 transcript isoforms
were identiﬁed to be diﬀerentially distributed in the
HepG2 and HeLa cell lines. Only 19% of them were
enriched in the same sub-cellular location in both cell
lines. About 3% of them were enriched in one location
for HepG2 but the other location for HeLa. The
remaining transcript isoforms (78%) were speciﬁc to
either cell line. This was not totally due to cell type-speciﬁc
transcription. For those transcript isoforms diﬀerentially
distributed in only one cell line, 77.2–80.5% of them were
present in the other cell line. In summary, in addition to
‘being expressed’ or ‘not being expressed’, ‘being in the
nucleus’ or ‘being in the cytosol’ may be another type of
cell-speciﬁc gene expression regulation. The mRNA
nucleocytoplasmic compartmentalization can be another
ﬁngerprint of cell identity.
Despite the cell-speciﬁc inventories of nuclear and
cytosolic isoforms, the global features of the nuclear and
cytosolic isoforms were similar between the two cell
lines. This indicates that the two cell lines may have
similar mechanisms to control the nucleocytoplasmic
compartmentalization. Our genome-wide analyses
revealed many diﬀerences between the nuclear and
cytosolic isoforms. For example, the cytosolic isoforms
had more introns than the nuclear isoforms. The intron
number reﬂects exon–exon junction number. Thus, the
results can be at least partially explained by the observa-
tion that splicing and consequently the EJC on exon–exon
junction are important for an eﬃcient nuclear export.
Nevertheless, two studies reported little eﬀect of splicing
on nuclear export (45,46), so there is probably a large
variation in the magnitude of the intron eﬀect on individ-
ual transcript isoforms. Our results also show that the
introns speciﬁc to the cytosolic isoforms tended to be
much longer (Table 1) and more conserved than those
speciﬁc to the nuclear isoforms. The total intronic propor-
tions were also higher in the cytosolic isoforms (Figure 2).
These results indicate that the involvement of introns in
the nucleocytoplasmic compartmentalization involves
more than just the exon–exon junction number. The
intron length may be another variable leading to
the large variation in the magnitude of the intron eﬀect.
But the mechanisms of how an intron aﬀects the
nucleocytoplasmic compartmentalization remain to be
clariﬁed experimentally.
The eﬀects of mRNA decay on the nucleocytoplasmic
distribution also vary depending on the trigger of the
mRNA degradation in the cytosol. We have particularly
explored the miRNA- and NMD-mediated mRNA decay.
In either case, we had originally expected that their targets
would be enriched in the nucleus instead of the cytosol. To
our surprise, the cytosolic isoforms tended to have
miRNA targets and the miRNA expression did not have
a signiﬁcant impact on the isoforms’ nucleocytosolic
location. Initial studies show that the mRNA levels of
miRNA target genes remain mostly unchanged in
animals, but more recent studies show that miRNAs can
induce some target mRNA degradation (32,33). Our
results do not necessarily argue against either observation.
However, they do suggest that the eﬀect of miRNA-
mediated mRNA decay is, if not modest, then at least
less substantial than the eﬀects of nuclear export and
other mechanisms in determining the nucleocytoplasmic
compartmentalization of the transcript isoforms. On the
other hand, the process of miRNA target recognition
takes place in the cytosol. One can speculate that if a tran-
script is a potential miRNA target, it will tend to be
enriched in the cytosol so that the miRNA can act on it
eﬃciently upon induction. The above results also indicate
that the nucleocytoplasmic location may be another
feature we can integrate into miRNA target prediction.
In contrast to the miRNA eﬀect, NMD-mediated decay
was signiﬁcantly more associated with the nuclear
isoforms, although some NMD targets were also cytosolic
isoforms.
The comparison of the evolutionary conservation shows
that the cytosolic isoforms tended to be more conserved
than the nuclear isoforms (Figure 5). Parmley et al. (47)
found that the evolutionary rates are reduced near intron–
exon boundaries and are reduced in intron-rich genes
more generally. Thus, the cytosolic isoforms are conse-
quently more conserved because they contain more
introns. Marais et al. (48) found a negative correlation
between intron size and exon evolution in Drosophila.
Our discoveries that cytosolic transcripts have longer
introns and more conserved exons in human cells are con-
sistent with their ﬁndings. The results also imply that
nuclear isoforms may contain more relatively newly
evolved transcript isoforms or ‘junk’ transcript isoforms
resulting from random splicing events. We also note that
some of the exonic positions speciﬁc to the nuclear
isoforms were highly conserved (Figure 5B). Most likely
there is a functional signiﬁcance for the enrichment of
these isoforms in the nucleus. In order to prevent inappro-
priate or malicious protein expression, these transcript
isoforms may not be able to pass scrutiny during nuclear
export. This eventually results in their enrichment in the
nucleus. The enriched functional RNA folds, and miRNA
targets in the cytosolic isoforms further indicate the selec-
tion pressure on the cytosolic isoforms.
Several of our results indicate that the 30 UTRs are
important for the transcript enrichment in the cytosol.
First, the exonic positions speciﬁc to the cytosolic
isoforms were enriched in the 30 regions (Figure 6A and D).
However, the exonic positions speciﬁc to the nuclear
isoforms were relatively more evenly distributed and
with a slight excess in the middle regions of genes
(Figure 6B and E). Second, the cytosolic isoforms
tended to have more functional RNA folds in their
30 region than the nuclear isoforms, perhaps because
those RNA folds contain mRNA localization signals,
facilitate mRNA export, or stabilize the mRNA in the
cytosol. The detailed mechanisms need to be explored
through experimental approaches.
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